LIGAND PHARMACEUTICALS INC Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Ligand Pharmaceuticals Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Ligand Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$7.17M, a 30.2% increase year-over-year.
  • Ligand Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $45.2M, a 175% increase year-over-year.
  • Ligand Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2023 was $52.2M.
  • Ligand Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$33.4M, a 158% decline from 2021.
  • Ligand Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2021 was $57.1M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $52.2M +$85.5M Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 -$33.4M -$90.5M -158% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $57.1M +$60.1M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 -$2.99M -$632M -100% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $629M +$486M +339% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $143M +$131M +1041% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $12.6M +$14.2M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 -$1.64M -$231M -101% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $230M +$218M +1811% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 $12M +$604K +5.29% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
2013 $11.4M +$11.9M Jan 1, 2013 Dec 31, 2013 10-K/A 2016-11-15
2012 -$527K -$10.2M -105% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-23
2011 $9.72M +$20.1M Jan 1, 2011 Dec 31, 2011 10-K/A 2014-12-12
2010 -$10.4M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.